Doxorubicin pathways: pharmacodynamics and adverse effects : Pharmacogenetics and Genomics (original) (raw)

PHARMGKB SUMMARY

pharmacodynamics and adverse effects

Thorn, Caroline F.; Oshiro, Connie; Marsh, Sharon; Hernandez-Boussard, Tina; McLeod, Howard; Klein, Teri E.; Altman, Russ B.

aDepartments of Genetics

bSurgery

cBioengineering, Stanford University Medical Center, Stanford, California

dInstitute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, North Carolina, USA

eFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada

Correspondence to Dr Teri E. Klein, PhD, Department of Genetics, Stanford University Medical Center, 300 Pasteur D. Lane L301, Mail Code 5120, Stanford, California 94305-5120, USA Tel: +1 650 7250659; fax: +1 650 7253863; e-mail: [email protected]

Received March 31, 2010

Accepted August 29, 2010